TechNavio today launched its report, Global H1N1 Vaccines Market 2011-2015, based on an in-depth analysis covering the Americas, and the EMEA and APAC regions. The report aims to aid decision makers’ understanding of the present and future landscape of the market.
Commenting on the report, an analyst from TechNavio’s Healthcare team said: ”In most of the developed countries, there is an increased focus on pre-pandemic vaccination. Various governing bodies are aiming at immunizing people years in advance against a flu pandemic. The focus is to avoid a rush to create vaccines once a new pandemic starts. Vaccine manufacturers are involved in producing pre-pandemic vaccines for better preparedness for the next major outbreak.”
According to the report, one of the key drivers witnessed in this market is the increase in the awareness among people in developed nations. As a result of the growing level of awareness, many people are getting themselves and their family vaccinated on their own accord. Significant support from both governmental and non-governmental agencies is helping to educate the public regarding the importance of personal hygiene. These agencies are also helping in educating the people about various vaccines available against the H1N1 virus.
Further, the report reveals that one of the key challenges is the easing pandemic situation.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. For further information on this report, please visit https://www.technavio.com/content/global-h1n1-vaccines-market-2011-2015
TechNavio, the market research platform of Infiniti Research Ltd, publishes periodic market research reports on niche and emerging technologies. For more information on our Healthcare market research, please visit https://www.technavio.com/healthcare
Follow us on Twitter @ Technavio